Stavudine, lamivudine, and indinavir in non-naive HIV-infected patients

被引：0
|
作者：
Rocca, B [1 ]
Minguez, C [1 ]
Andrés, J [1 ]
Usó, J [1 ]
Sáez-Royuela, A [1 ]
Simón, E [1 ]
机构：
[1] Hosp Gen Castellon, Castellon 12004, Spain
来源：
AIDS | 1998年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P116
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [1] Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients:: Adherence, side effects and efficacy
    Roca, B
    Gómez, CJ
    Arnedo, A
    [J]. JOURNAL OF INFECTION, 1999, 39 (02) : 141 - 145
  • [2] A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients
    Roca, B
    Gómez, CJ
    Arnedo, A
    [J]. AIDS, 2000, 14 (02) : 157 - 161
  • [3] Population pharmacokinetic analysisof lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART
    Xavière Panhard
    Mayeule Legrand
    Anne-Marie Taburet
    Bertrand Diquet
    Cécile Goujard
    France Mentré
    [J]. European Journal of Clinical Pharmacology, 2007, 63 : 1019 - 1029
  • [4] Population pharmacokinetic analysisof lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART
    Panhard, Xaviere
    Legrand, Mayeule
    Taburet, Anne-Marie
    Diquet, Bertrand
    Goujard, Cecile
    Mentre, France
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (11) : 1019 - 1029
  • [5] Nephrolithiasis in HIV-infected patients treated with indinavir
    Rodriguez-Rosado, R
    Jimenez-Nacher, I
    Valencia, E
    Soriano, V
    Gonzalez-Lahoz, JG
    [J]. ANTIVIRAL THERAPY, 1998, 3 (02) : 113 - 113
  • [6] Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial
    Staszewski, S
    Keiser, P
    Montaner, J
    Raffi, F
    Gathe, J
    Brotas, V
    Hicks, C
    Hammer, SM
    Cooper, D
    Johnson, M
    Tortell, S
    Cutrell, A
    Thorborn, D
    Isaacs, R
    Hetherington, S
    Steel, H
    Spreen, W
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (09): : 1155 - 1163
  • [7] Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks
    Murphy, RL
    [J]. ANTIVIRAL THERAPY, 1999, 4 : 85 - 87
  • [8] Genotypic resistance in HIV-Infected naive patients receiving abacavir plus lamivudine and efavirenz
    Ferrer, Elena
    Niubo, Jordi
    Crespo, Manuel
    Gatell, Josep Maria
    Sanz, Jose
    Veloso, Sergio
    Llibre, Josep Maria
    Barrufet, Pilar
    Sanchez, Pochita
    Podzamczer, Daniel
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) : 253 - 255
  • [9] Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109)
    Launay, Odile
    Duval, Xavier
    Dalban, Cecile
    Descamps, Diane
    Peytavin, Gilles
    Certain, Agnes
    Mouajjah, Said
    Ralaimazava, Pascal
    Verdon, Renaud
    Costagliola, Dominique
    Clavel, Francois
    [J]. ANTIVIRAL THERAPY, 2006, 11 (07) : 889 - 899
  • [10] Effect of indinavir on the pharmacokinetics of rifampicin in HIV-infected patients
    Jaruratanasirikul, S
    Sriwiriyajan, S
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (03) : 409 - 412
12345